IGM Biosciences, Inc.
MULTIMERIC CD137/4-1BB BINDING MOLECULES AND USES THEREOF

Abstract:

This disclosure provides dimeric, pentameric, and hexameric CD137/4-1BB agonist binding molecules and methods of using such binding molecules to induce anti-tumor immunity.